Advertisement

Index by Author

September 2000; 49 (9)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Aabenhus Andersen, N

    • The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells. Diabetes September 2000 49:1468-1476; doi:10.2337/diabetes.49.9.1468

  2. Ahn, Y H

    • Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter. Diabetes September 2000 49:1517-1524; doi:10.2337/diabetes.49.9.1517

  3. Almgren, P

    • Association between the human glycoprotein PC-1 gene and elevated glucose and insulin levels in a paired-sibling analysis. Diabetes September 2000 49:1601-1603; doi:10.2337/diabetes.49.9.1601

  4. Altmüller, J

    • Type 2 diabetes-like hyperglycemia in a backcross model of NZO and SJL mice: characterization of a susceptibility locus on chromosome 4 and its relation with obesity. Diabetes September 2000 49:1590-1596; doi:10.2337/diabetes.49.9.1590

  5. Ammendrup, A

    • The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells. Diabetes September 2000 49:1468-1476; doi:10.2337/diabetes.49.9.1468

  6. Armitage, N

    • Analysis of the mouse CD30 gene: a candidate for the NOD mouse type 1 diabetes locus Idd9.2. Diabetes September 2000 49:1612-1616; doi:10.2337/diabetes.49.9.1612

B

  1. Bae, Y S

    • Prevention of encephalomyocarditis virus-induced diabetes by live recombinant Mycobacterium bovis bacillus Calmette-Guérin in susceptible mice. Diabetes September 2000 49:1459-1467; doi:10.2337/diabetes.49.9.1459

  2. Bai, G H

    • Prevention of encephalomyocarditis virus-induced diabetes by live recombinant Mycobacterium bovis bacillus Calmette-Guérin in susceptible mice. Diabetes September 2000 49:1459-1467; doi:10.2337/diabetes.49.9.1459

  3. Barg, S

    • Tight coupling between electrical activity and exocytosis in mouse glucagon-secreting alpha-cells. Diabetes September 2000 49:1500-1510; doi:10.2337/diabetes.49.9.1500

  4. Barker, C J

    • Phosphatidylinositol 4,5-bisphosphate and ATP-sensitive potassium channel regulation: a word of caution. Diabetes September 2000 49:1409-1412; doi:10.2337/diabetes.49.9.1409

  5. Battezzati, A

    • Effect of hypoglycemia on amino acid and protein metabolism in healthy humans. Diabetes September 2000 49:1543-1551; doi:10.2337/diabetes.49.9.1543

  6. Becker, D J

    • Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women. Diabetes September 2000 49:1571-1578; doi:10.2337/diabetes.49.9.1571

  7. Benedini, S

    • Effect of hypoglycemia on amino acid and protein metabolism in healthy humans. Diabetes September 2000 49:1543-1551; doi:10.2337/diabetes.49.9.1543

  8. Berdal, M

    • Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes September 2000 49:1451-1458; doi:10.2337/diabetes.49.9.1451

  9. Bergans, N

    • Molecular mode of inhibition of glycogenolysis in rat liver by the dihydropyridine derivative, BAY R3401: inhibition and inactivation of glycogen phosphorylase by an activated metabolite. Diabetes September 2000 49:1419-1426; doi:10.2337/diabetes.49.9.1419

  10. Berggren, P O

    • Phosphatidylinositol 4,5-bisphosphate and ATP-sensitive potassium channel regulation: a word of caution. Diabetes September 2000 49:1409-1412; doi:10.2337/diabetes.49.9.1409

  11. Bierhaus, A

    • Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. Diabetes September 2000 49:1561-1570; doi:10.2337/diabetes.49.9.1561

  12. Bonny, C

    • The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells. Diabetes September 2000 49:1468-1476; doi:10.2337/diabetes.49.9.1468

  13. Borch-Johnsen, K

    • The K121Q variant of the human PC-1 gene is not associated with insulin resistance or type 2 diabetes among Danish Caucasians. Diabetes September 2000 49:1608-1611; doi:10.2337/diabetes.49.9.1608

  14. Briedigkeit, L

    • Heterozygous expansion of the GAA tract of the X25/frataxin gene is associated with insulin resistance in humans. Diabetes September 2000 49:1604-1607; doi:10.2337/diabetes.49.9.1604

C

  1. Caramori, M L

    • The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes September 2000 49:1399-1408; doi:10.2337/diabetes.49.9.1399

  2. Cha, J Y

    • Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter. Diabetes September 2000 49:1517-1524; doi:10.2337/diabetes.49.9.1517

  3. Chan, J G

    • Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage. Diabetes September 2000 49:1579-1584; doi:10.2337/diabetes.49.9.1579

  4. Choe, Y K

    • Prevention of encephalomyocarditis virus-induced diabetes by live recombinant Mycobacterium bovis bacillus Calmette-Guérin in susceptible mice. Diabetes September 2000 49:1459-1467; doi:10.2337/diabetes.49.9.1459

  5. Choi, B K

    • Prevention of encephalomyocarditis virus-induced diabetes by live recombinant Mycobacterium bovis bacillus Calmette-Guérin in susceptible mice. Diabetes September 2000 49:1459-1467; doi:10.2337/diabetes.49.9.1459

  6. Cho, S H

    • Prevention of encephalomyocarditis virus-induced diabetes by live recombinant Mycobacterium bovis bacillus Calmette-Guérin in susceptible mice. Diabetes September 2000 49:1459-1467; doi:10.2337/diabetes.49.9.1459

  7. Coker, R H

    • Evidence that carotid bodies play an important role in glucoregulation in vivo. Diabetes September 2000 49:1434-1442; doi:10.2337/diabetes.49.9.1434

  8. Comper, W D

    • Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage. Diabetes September 2000 49:1579-1584; doi:10.2337/diabetes.49.9.1579

  9. Cooksey, R C

    • Transgenic mice with increased hexosamine flux specifically targeted to beta-cells exhibit hyperinsulinemia and peripheral insulin resistance. Diabetes September 2000 49:1492-1499; doi:10.2337/diabetes.49.9.1492

  10. Cooney, G J

    • Local factors modulate tissue-specific NEFA utilization: assessment in rats using 3H-(R)-2-bromopalmitate. Diabetes September 2000 49:1427-1433; doi:10.2337/diabetes.49.9.1427

  11. Corkey, B E

    • Oxygen consumption oscillates in single clonal pancreatic beta-cells (HIT). Diabetes September 2000 49:1511-1516; doi:10.2337/diabetes.49.9.1511

  12. Corkey, R F

    • Oxygen consumption oscillates in single clonal pancreatic beta-cells (HIT). Diabetes September 2000 49:1511-1516; doi:10.2337/diabetes.49.9.1511

D

  1. D'Alessio, D A

    • The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells. Diabetes September 2000 49:1477-1484; doi:10.2337/diabetes.49.9.1477

  2. Dembski, M

    • Identification of leptin-induced transcripts in the mouse hypothalamus. Diabetes September 2000 49:1443-1450; doi:10.2337/diabetes.49.9.1443

  3. Dragsbaek Madsen, O

    • The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells. Diabetes September 2000 49:1468-1476; doi:10.2337/diabetes.49.9.1468

  4. Drucker, D J

    • Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action. Diabetes September 2000 49:1552-1560; doi:10.2337/diabetes.49.9.1552

  5. Dupraz, P

    • Glucose uptake, utilization, and signaling in GLUT2-null islets. Diabetes September 2000 49:1485-1491; doi:10.2337/diabetes.49.9.1485

E

  1. Echwald, S M

    • The K121Q variant of the human PC-1 gene is not associated with insulin resistance or type 2 diabetes among Danish Caucasians. Diabetes September 2000 49:1608-1611; doi:10.2337/diabetes.49.9.1608

  2. Edmundowicz, D

    • Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women. Diabetes September 2000 49:1571-1578; doi:10.2337/diabetes.49.9.1571

  3. Ekstrøm, C T

    • The K121Q variant of the human PC-1 gene is not associated with insulin resistance or type 2 diabetes among Danish Caucasians. Diabetes September 2000 49:1608-1611; doi:10.2337/diabetes.49.9.1608

  4. Eliasson, L

    • Tight coupling between electrical activity and exocytosis in mouse glucagon-secreting alpha-cells. Diabetes September 2000 49:1500-1510; doi:10.2337/diabetes.49.9.1500

  5. Ezaki, O

    • Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes September 2000 49:1534-1542; doi:10.2337/diabetes.49.9.1534

F

  1. Fasching, P

    • Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. Diabetes September 2000 49:1561-1570; doi:10.2337/diabetes.49.9.1561

  2. Fattorini, A

    • Effect of hypoglycemia on amino acid and protein metabolism in healthy humans. Diabetes September 2000 49:1543-1551; doi:10.2337/diabetes.49.9.1543

  3. Fioretto, P

    • The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes September 2000 49:1399-1408; doi:10.2337/diabetes.49.9.1399

  4. Frittitta, L

    • Association between the human glycoprotein PC-1 gene and elevated glucose and insulin levels in a paired-sibling analysis. Diabetes September 2000 49:1601-1603; doi:10.2337/diabetes.49.9.1601
    • The K121Q variant of the human PC-1 gene is not associated with insulin resistance or type 2 diabetes among Danish Caucasians. Diabetes September 2000 49:1608-1611; doi:10.2337/diabetes.49.9.1608

  5. Furler, S M

    • Local factors modulate tissue-specific NEFA utilization: assessment in rats using 3H-(R)-2-bromopalmitate. Diabetes September 2000 49:1427-1433; doi:10.2337/diabetes.49.9.1427

  6. Furuta, H

    • Nonsense mutation of islet-1 gene (Q310X) found in a type 2 diabetic patient with a strong family history. Diabetes September 2000 49:1597-1600; doi:10.2337/diabetes.49.9.1597

G

  1. Galvanovskis, J

    • Tight coupling between electrical activity and exocytosis in mouse glucagon-secreting alpha-cells. Diabetes September 2000 49:1500-1510; doi:10.2337/diabetes.49.9.1500

  2. Ge, P

    • Identification of leptin-induced transcripts in the mouse hypothalamus. Diabetes September 2000 49:1443-1450; doi:10.2337/diabetes.49.9.1443

  3. Giesen, K

    • Type 2 diabetes-like hyperglycemia in a backcross model of NZO and SJL mice: characterization of a susceptibility locus on chromosome 4 and its relation with obesity. Diabetes September 2000 49:1590-1596; doi:10.2337/diabetes.49.9.1590

  4. Goldmann, S

    • Molecular mode of inhibition of glycogenolysis in rat liver by the dihydropyridine derivative, BAY R3401: inhibition and inactivation of glycogen phosphorylase by an activated metabolite. Diabetes September 2000 49:1419-1426; doi:10.2337/diabetes.49.9.1419

  5. Göpel, S O

    • Tight coupling between electrical activity and exocytosis in mouse glucagon-secreting alpha-cells. Diabetes September 2000 49:1500-1510; doi:10.2337/diabetes.49.9.1500

  6. Groop, L C

    • Association between the human glycoprotein PC-1 gene and elevated glucose and insulin levels in a paired-sibling analysis. Diabetes September 2000 49:1601-1603; doi:10.2337/diabetes.49.9.1601

  7. Gu, H F

    • Association between the human glycoprotein PC-1 gene and elevated glucose and insulin levels in a paired-sibling analysis. Diabetes September 2000 49:1601-1603; doi:10.2337/diabetes.49.9.1601

  8. Guillam, M T

    • Glucose uptake, utilization, and signaling in GLUT2-null islets. Diabetes September 2000 49:1485-1491; doi:10.2337/diabetes.49.9.1485

H

  1. Hanabusa, T

    • Nonsense mutation of islet-1 gene (Q310X) found in a type 2 diabetic patient with a strong family history. Diabetes September 2000 49:1597-1600; doi:10.2337/diabetes.49.9.1597

  2. Hansen, L

    • The K121Q variant of the human PC-1 gene is not associated with insulin resistance or type 2 diabetes among Danish Caucasians. Diabetes September 2000 49:1608-1611; doi:10.2337/diabetes.49.9.1608

  3. Hansen, T

    • The K121Q variant of the human PC-1 gene is not associated with insulin resistance or type 2 diabetes among Danish Caucasians. Diabetes September 2000 49:1608-1611; doi:10.2337/diabetes.49.9.1608

  4. Hardt, C

    • Heterozygous expansion of the GAA tract of the X25/frataxin gene is associated with insulin resistance in humans. Diabetes September 2000 49:1604-1607; doi:10.2337/diabetes.49.9.1604

  5. Hebinck, J

    • Heterozygous expansion of the GAA tract of the X25/frataxin gene is associated with insulin resistance in humans. Diabetes September 2000 49:1604-1607; doi:10.2337/diabetes.49.9.1604

  6. Hegarty, B D

    • Local factors modulate tissue-specific NEFA utilization: assessment in rats using 3H-(R)-2-bromopalmitate. Diabetes September 2000 49:1427-1433; doi:10.2337/diabetes.49.9.1427

  7. Hill, M E

    • Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action. Diabetes September 2000 49:1552-1560; doi:10.2337/diabetes.49.9.1552

  8. Hong, M

    • Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. Diabetes September 2000 49:1561-1570; doi:10.2337/diabetes.49.9.1561

  9. Houlihan, C A

    • Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage. Diabetes September 2000 49:1579-1584; doi:10.2337/diabetes.49.9.1579

  10. Hull, R L

    • The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells. Diabetes September 2000 49:1477-1484; doi:10.2337/diabetes.49.9.1477

  11. Hyun, B H

    • Prevention of encephalomyocarditis virus-induced diabetes by live recombinant Mycobacterium bovis bacillus Calmette-Guérin in susceptible mice. Diabetes September 2000 49:1459-1467; doi:10.2337/diabetes.49.9.1459

I

  1. Ikemoto, S

    • Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes September 2000 49:1534-1542; doi:10.2337/diabetes.49.9.1534

J

  1. Jabbour, K

    • Evidence that carotid bodies play an important role in glucoregulation in vivo. Diabetes September 2000 49:1434-1442; doi:10.2337/diabetes.49.9.1434

  2. Jenssen, T G

    • Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes September 2000 49:1451-1458; doi:10.2337/diabetes.49.9.1451

  3. Jerums, G

    • Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage. Diabetes September 2000 49:1579-1584; doi:10.2337/diabetes.49.9.1579

  4. Joost, H G

    • Type 2 diabetes-like hyperglycemia in a backcross model of NZO and SJL mice: characterization of a susceptibility locus on chromosome 4 and its relation with obesity. Diabetes September 2000 49:1590-1596; doi:10.2337/diabetes.49.9.1590

K

  1. Kahn, C R

    • Heterozygous expansion of the GAA tract of the X25/frataxin gene is associated with insulin resistance in humans. Diabetes September 2000 49:1604-1607; doi:10.2337/diabetes.49.9.1604

  2. Kahn, S E

    • The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells. Diabetes September 2000 49:1477-1484; doi:10.2337/diabetes.49.9.1477
    • Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes September 2000 49:1525-1533; doi:10.2337/diabetes.49.9.1525

  3. Kaiyala, K J

    • Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes September 2000 49:1525-1533; doi:10.2337/diabetes.49.9.1525

  4. Kasai, M

    • Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes September 2000 49:1534-1542; doi:10.2337/diabetes.49.9.1534

  5. Kim, H I

    • Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter. Diabetes September 2000 49:1517-1524; doi:10.2337/diabetes.49.9.1517

  6. Kim, H J

    • Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes September 2000 49:1534-1542; doi:10.2337/diabetes.49.9.1534

  7. Kim, J W

    • Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter. Diabetes September 2000 49:1517-1524; doi:10.2337/diabetes.49.9.1517

  8. Kim, K S

    • Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter. Diabetes September 2000 49:1517-1524; doi:10.2337/diabetes.49.9.1517

  9. Kim, S H

    • Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter. Diabetes September 2000 49:1517-1524; doi:10.2337/diabetes.49.9.1517

  10. Kim, S J

    • Prevention of encephalomyocarditis virus-induced diabetes by live recombinant Mycobacterium bovis bacillus Calmette-Guérin in susceptible mice. Diabetes September 2000 49:1459-1467; doi:10.2337/diabetes.49.9.1459

  11. Klevesath, M

    • Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. Diabetes September 2000 49:1561-1570; doi:10.2337/diabetes.49.9.1561

  12. Kluge, R

    • Type 2 diabetes-like hyperglycemia in a backcross model of NZO and SJL mice: characterization of a susceptibility locus on chromosome 4 and its relation with obesity. Diabetes September 2000 49:1590-1596; doi:10.2337/diabetes.49.9.1590

  13. Koyama, Y

    • Evidence that carotid bodies play an important role in glucoregulation in vivo. Diabetes September 2000 49:1434-1442; doi:10.2337/diabetes.49.9.1434

  14. Kraegen, E W

    • Local factors modulate tissue-specific NEFA utilization: assessment in rats using 3H-(R)-2-bromopalmitate. Diabetes September 2000 49:1427-1433; doi:10.2337/diabetes.49.9.1427

  15. Kuller, L H

    • Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women. Diabetes September 2000 49:1571-1578; doi:10.2337/diabetes.49.9.1571

L

  1. Lacy, D B

    • Evidence that carotid bodies play an important role in glucoregulation in vivo. Diabetes September 2000 49:1434-1442; doi:10.2337/diabetes.49.9.1434

  2. Larsson, O

    • Phosphatidylinositol 4,5-bisphosphate and ATP-sensitive potassium channel regulation: a word of caution. Diabetes September 2000 49:1409-1412; doi:10.2337/diabetes.49.9.1409

  3. Lim-Fraser, M Y

    • Local factors modulate tissue-specific NEFA utilization: assessment in rats using 3H-(R)-2-bromopalmitate. Diabetes September 2000 49:1427-1433; doi:10.2337/diabetes.49.9.1427

  4. Lindholm, E

    • Association between the human glycoprotein PC-1 gene and elevated glucose and insulin levels in a paired-sibling analysis. Diabetes September 2000 49:1601-1603; doi:10.2337/diabetes.49.9.1601

  5. Luzi, L

    • Effect of hypoglycemia on amino acid and protein metabolism in healthy humans. Diabetes September 2000 49:1543-1551; doi:10.2337/diabetes.49.9.1543

  6. Lyons, P A

    • Analysis of the mouse CD30 gene: a candidate for the NOD mouse type 1 diabetes locus Idd9.2. Diabetes September 2000 49:1612-1616; doi:10.2337/diabetes.49.9.1612

M

  1. Maillard, A

    • The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells. Diabetes September 2000 49:1468-1476; doi:10.2337/diabetes.49.9.1468

  2. Mandrup-Poulsen, T

    • The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells. Diabetes September 2000 49:1468-1476; doi:10.2337/diabetes.49.9.1468

  3. Markworth, E

    • ATP4- mediates closure of pancreatic beta-cell ATP-sensitive potassium channels by interaction with 1 of 4 identical sites. Diabetes September 2000 49:1413-1418; doi:10.2337/diabetes.49.9.1413

  4. Mauer, M

    • The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes September 2000 49:1399-1408; doi:10.2337/diabetes.49.9.1399

  5. McClain, D A

    • Transgenic mice with increased hexosamine flux specifically targeted to beta-cells exhibit hyperinsulinemia and peripheral insulin resistance. Diabetes September 2000 49:1492-1499; doi:10.2337/diabetes.49.9.1492

  6. Miller, J A

    • Angiotensin II type 1 receptor gene polymorphism and the response to hyperglycemia in early type 1 diabetes. Diabetes September 2000 49:1585-1589; doi:10.2337/diabetes.49.9.1585

  7. Morgenstern, J P

    • Identification of leptin-induced transcripts in the mouse hypothalamus. Diabetes September 2000 49:1443-1450; doi:10.2337/diabetes.49.9.1443

  8. Muellner, C

    • Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. Diabetes September 2000 49:1561-1570; doi:10.2337/diabetes.49.9.1561

  9. Myklebust, R

    • Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes September 2000 49:1451-1458; doi:10.2337/diabetes.49.9.1451

N

  1. Nanjo, K

    • Nonsense mutation of islet-1 gene (Q310X) found in a type 2 diabetic patient with a strong family history. Diabetes September 2000 49:1597-1600; doi:10.2337/diabetes.49.9.1597

  2. Nawroth, P P

    • Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. Diabetes September 2000 49:1561-1570; doi:10.2337/diabetes.49.9.1561

  3. Neidigh, J L

    • Transgenic mice with increased hexosamine flux specifically targeted to beta-cells exhibit hyperinsulinemia and peripheral insulin resistance. Diabetes September 2000 49:1492-1499; doi:10.2337/diabetes.49.9.1492

  4. Nielsen, K

    • The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells. Diabetes September 2000 49:1468-1476; doi:10.2337/diabetes.49.9.1468

O

  1. Oakes, N D

    • Local factors modulate tissue-specific NEFA utilization: assessment in rats using 3H-(R)-2-bromopalmitate. Diabetes September 2000 49:1427-1433; doi:10.2337/diabetes.49.9.1427

  2. Okuyama, H

    • Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes September 2000 49:1534-1542; doi:10.2337/diabetes.49.9.1534

  3. Olsen, R

    • Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes September 2000 49:1451-1458; doi:10.2337/diabetes.49.9.1451

  4. Olson, J C

    • Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women. Diabetes September 2000 49:1571-1578; doi:10.2337/diabetes.49.9.1571

  5. Orchard, T J

    • Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women. Diabetes September 2000 49:1571-1578; doi:10.2337/diabetes.49.9.1571

  6. Ortlepp, J R

    • Type 2 diabetes-like hyperglycemia in a backcross model of NZO and SJL mice: characterization of a susceptibility locus on chromosome 4 and its relation with obesity. Diabetes September 2000 49:1590-1596; doi:10.2337/diabetes.49.9.1590

  7. Osicka, T M

    • Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage. Diabetes September 2000 49:1579-1584; doi:10.2337/diabetes.49.9.1579

P

  1. Pedersen, O

    • The K121Q variant of the human PC-1 gene is not associated with insulin resistance or type 2 diabetes among Danish Caucasians. Diabetes September 2000 49:1608-1611; doi:10.2337/diabetes.49.9.1608

  2. Perkins, B

    • Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action. Diabetes September 2000 49:1552-1560; doi:10.2337/diabetes.49.9.1552

  3. Peterson, L B

    • Analysis of the mouse CD30 gene: a candidate for the NOD mouse type 1 diabetes locus Idd9.2. Diabetes September 2000 49:1612-1616; doi:10.2337/diabetes.49.9.1612

  4. Piceni Sereni, L

    • Effect of hypoglycemia on amino acid and protein metabolism in healthy humans. Diabetes September 2000 49:1543-1551; doi:10.2337/diabetes.49.9.1543

  5. Pizzuti, A

    • Association between the human glycoprotein PC-1 gene and elevated glucose and insulin levels in a paired-sibling analysis. Diabetes September 2000 49:1601-1603; doi:10.2337/diabetes.49.9.1601
    • The K121Q variant of the human PC-1 gene is not associated with insulin resistance or type 2 diabetes among Danish Caucasians. Diabetes September 2000 49:1608-1611; doi:10.2337/diabetes.49.9.1608

  6. Plum, L

    • Type 2 diabetes-like hyperglycemia in a backcross model of NZO and SJL mice: characterization of a susceptibility locus on chromosome 4 and its relation with obesity. Diabetes September 2000 49:1590-1596; doi:10.2337/diabetes.49.9.1590

  7. Porterfield, D M

    • Oxygen consumption oscillates in single clonal pancreatic beta-cells (HIT). Diabetes September 2000 49:1511-1516; doi:10.2337/diabetes.49.9.1511

  8. Prigeon, R L

    • The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells. Diabetes September 2000 49:1477-1484; doi:10.2337/diabetes.49.9.1477
    • Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes September 2000 49:1525-1533; doi:10.2337/diabetes.49.9.1525

Q

  1. Quehenberger, P

    • Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. Diabetes September 2000 49:1561-1570; doi:10.2337/diabetes.49.9.1561

R

  1. Rasmussen, S K

    • The K121Q variant of the human PC-1 gene is not associated with insulin resistance or type 2 diabetes among Danish Caucasians. Diabetes September 2000 49:1608-1611; doi:10.2337/diabetes.49.9.1608

  2. Ristow, M

    • Heterozygous expansion of the GAA tract of the X25/frataxin gene is associated with insulin resistance in humans. Diabetes September 2000 49:1604-1607; doi:10.2337/diabetes.49.9.1604

  3. Rorsman, P

    • Tight coupling between electrical activity and exocytosis in mouse glucagon-secreting alpha-cells. Diabetes September 2000 49:1500-1510; doi:10.2337/diabetes.49.9.1500

S

  1. Saleh, J

    • Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action. Diabetes September 2000 49:1552-1560; doi:10.2337/diabetes.49.9.1552

  2. Sanger, R H

    • Oxygen consumption oscillates in single clonal pancreatic beta-cells (HIT). Diabetes September 2000 49:1511-1516; doi:10.2337/diabetes.49.9.1511

  3. Sanke, T

    • Nonsense mutation of islet-1 gene (Q310X) found in a type 2 diabetic patient with a strong family history. Diabetes September 2000 49:1597-1600; doi:10.2337/diabetes.49.9.1597

  4. Sattler, M

    • Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. Diabetes September 2000 49:1561-1570; doi:10.2337/diabetes.49.9.1561

  5. Schleicher, E

    • Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. Diabetes September 2000 49:1561-1570; doi:10.2337/diabetes.49.9.1561

  6. Scholey, J W

    • Angiotensin II type 1 receptor gene polymorphism and the response to hyperglycemia in early type 1 diabetes. Diabetes September 2000 49:1585-1589; doi:10.2337/diabetes.49.9.1585

  7. Schöls, L

    • Heterozygous expansion of the GAA tract of the X25/frataxin gene is associated with insulin resistance in humans. Diabetes September 2000 49:1604-1607; doi:10.2337/diabetes.49.9.1604

  8. Schwanstecher, C

    • ATP4- mediates closure of pancreatic beta-cell ATP-sensitive potassium channels by interaction with 1 of 4 identical sites. Diabetes September 2000 49:1413-1418; doi:10.2337/diabetes.49.9.1413

  9. Schwanstecher, M

    • ATP4- mediates closure of pancreatic beta-cell ATP-sensitive potassium channels by interaction with 1 of 4 identical sites. Diabetes September 2000 49:1413-1418; doi:10.2337/diabetes.49.9.1413

  10. Schwartz, M W

    • Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes September 2000 49:1525-1533; doi:10.2337/diabetes.49.9.1525

  11. Scrocchi, L A

    • Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action. Diabetes September 2000 49:1552-1560; doi:10.2337/diabetes.49.9.1552

  12. Seljelid, R

    • Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes September 2000 49:1451-1458; doi:10.2337/diabetes.49.9.1451

  13. Serup, P

    • The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells. Diabetes September 2000 49:1468-1476; doi:10.2337/diabetes.49.9.1468

  14. Shimomura, H

    • Nonsense mutation of islet-1 gene (Q310X) found in a type 2 diabetic patient with a strong family history. Diabetes September 2000 49:1597-1600; doi:10.2337/diabetes.49.9.1597

  15. Siegmund, T

    • Analysis of the mouse CD30 gene: a candidate for the NOD mouse type 1 diabetes locus Idd9.2. Diabetes September 2000 49:1612-1616; doi:10.2337/diabetes.49.9.1612

  16. Smith, P J

    • Oxygen consumption oscillates in single clonal pancreatic beta-cells (HIT). Diabetes September 2000 49:1511-1516; doi:10.2337/diabetes.49.9.1511

  17. Speiser, W

    • Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. Diabetes September 2000 49:1561-1570; doi:10.2337/diabetes.49.9.1561

  18. Stalmans, W

    • Molecular mode of inhibition of glycogenolysis in rat liver by the dihydropyridine derivative, BAY R3401: inhibition and inactivation of glycogen phosphorylase by an activated metabolite. Diabetes September 2000 49:1419-1426; doi:10.2337/diabetes.49.9.1419

  19. Stier, G

    • Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. Diabetes September 2000 49:1561-1570; doi:10.2337/diabetes.49.9.1561

  20. Stone, E E

    • Evidence that carotid bodies play an important role in glucoregulation in vivo. Diabetes September 2000 49:1434-1442; doi:10.2337/diabetes.49.9.1434

  21. Stricker-Krongrad, A

    • Identification of leptin-induced transcripts in the mouse hypothalamus. Diabetes September 2000 49:1443-1450; doi:10.2337/diabetes.49.9.1443

T

  1. Takahashi, M

    • Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes September 2000 49:1534-1542; doi:10.2337/diabetes.49.9.1534

  2. Tanemura, K

    • Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes September 2000 49:1534-1542; doi:10.2337/diabetes.49.9.1534

  3. Tange, T

    • Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes September 2000 49:1534-1542; doi:10.2337/diabetes.49.9.1534

  4. Tang, J

    • Transgenic mice with increased hexosamine flux specifically targeted to beta-cells exhibit hyperinsulinemia and peripheral insulin resistance. Diabetes September 2000 49:1492-1499; doi:10.2337/diabetes.49.9.1492

  5. Tartaglia, L A

    • Identification of leptin-induced transcripts in the mouse hypothalamus. Diabetes September 2000 49:1443-1450; doi:10.2337/diabetes.49.9.1443

  6. Thai, K

    • Angiotensin II type 1 receptor gene polymorphism and the response to hyperglycemia in early type 1 diabetes. Diabetes September 2000 49:1585-1589; doi:10.2337/diabetes.49.9.1585

  7. Thorens, B

    • Glucose uptake, utilization, and signaling in GLUT2-null islets. Diabetes September 2000 49:1485-1491; doi:10.2337/diabetes.49.9.1485

  8. Todd, J A

    • Analysis of the mouse CD30 gene: a candidate for the NOD mouse type 1 diabetes locus Idd9.2. Diabetes September 2000 49:1612-1616; doi:10.2337/diabetes.49.9.1612

  9. Tornheim, K

    • Oxygen consumption oscillates in single clonal pancreatic beta-cells (HIT). Diabetes September 2000 49:1511-1516; doi:10.2337/diabetes.49.9.1511

  10. Trischitta, V

    • Association between the human glycoprotein PC-1 gene and elevated glucose and insulin levels in a paired-sibling analysis. Diabetes September 2000 49:1601-1603; doi:10.2337/diabetes.49.9.1601
    • The K121Q variant of the human PC-1 gene is not associated with insulin resistance or type 2 diabetes among Danish Caucasians. Diabetes September 2000 49:1608-1611; doi:10.2337/diabetes.49.9.1608

  11. Tsuboyama-Kasaoka, N

    • Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes September 2000 49:1534-1542; doi:10.2337/diabetes.49.9.1534

  12. Tsunoda, K

    • Nonsense mutation of islet-1 gene (Q310X) found in a type 2 diabetic patient with a strong family history. Diabetes September 2000 49:1597-1600; doi:10.2337/diabetes.49.9.1597

U

  1. Urhammer, S A

    • The K121Q variant of the human PC-1 gene is not associated with insulin resistance or type 2 diabetes among Danish Caucasians. Diabetes September 2000 49:1608-1611; doi:10.2337/diabetes.49.9.1608

V

  1. Vanstapel, F

    • Molecular mode of inhibition of glycogenolysis in rat liver by the dihydropyridine derivative, BAY R3401: inhibition and inactivation of glycogen phosphorylase by an activated metabolite. Diabetes September 2000 49:1419-1426; doi:10.2337/diabetes.49.9.1419

  2. Verchere, C B

    • The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells. Diabetes September 2000 49:1477-1484; doi:10.2337/diabetes.49.9.1477

  3. Vorgerd, M

    • Heterozygous expansion of the GAA tract of the X25/frataxin gene is associated with insulin resistance in humans. Diabetes September 2000 49:1604-1607; doi:10.2337/diabetes.49.9.1604

W

  1. Wasserman, D H

    • Evidence that carotid bodies play an important role in glucoregulation in vivo. Diabetes September 2000 49:1434-1442; doi:10.2337/diabetes.49.9.1434

  2. White, D W

    • Identification of leptin-induced transcripts in the mouse hypothalamus. Diabetes September 2000 49:1443-1450; doi:10.2337/diabetes.49.9.1443

  3. Wicker, L S

    • Analysis of the mouse CD30 gene: a candidate for the NOD mouse type 1 diabetes locus Idd9.2. Diabetes September 2000 49:1612-1616; doi:10.2337/diabetes.49.9.1612

  4. Williams, P E

    • Evidence that carotid bodies play an important role in glucoregulation in vivo. Diabetes September 2000 49:1434-1442; doi:10.2337/diabetes.49.9.1434

  5. Woods, S C

    • Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes September 2000 49:1525-1533; doi:10.2337/diabetes.49.9.1525

Z

  1. Zhou, J

    • Identification of leptin-induced transcripts in the mouse hypothalamus. Diabetes September 2000 49:1443-1450; doi:10.2337/diabetes.49.9.1443

  2. Zykova, S N

    • Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes September 2000 49:1451-1458; doi:10.2337/diabetes.49.9.1451

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement